SCHEMBL6091239

SCHEMBL6091239

CCC(CC)(c1ccc(F)cc1)c1c[nH]c2ccc(OC)cc12

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MTNR1A P48039 1/20 0.50
MTNR1B P49286 1/20 0.50
HTR2A P28223 3/20 0.48
GPR84 Q9NQS5 2/20 0.48
SMN1; SMN2 Q16637 2/20 0.47
LMNA P02545 1/20 0.47
HTT P42858 1/20 0.47
MAPT P10636 3/20 0.46
HTR2B P41595 1/20 0.46
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46
HTR1A P08908 3/20 0.45
CYP1A2 P05177 2/20 0.44
CYP2D6 P10635 1/20 0.44
TSHR P16473 1/20 0.44
NFKB1 P19838 1/20 0.44
HTR1D P28221 1/20 0.44
HTR1B P28222 1/20 0.44
HTR2C P28335 1/20 0.44
HTR7 P34969 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6090628 0.87 GPR84 (0.47) HTR2AGPR84KMT2AHTR1AHTR2C
SCHEMBL6091133 0.79 NR4A2 (0.46) GPR84MAPTMEN1KMT2AALDH1A1
SCHEMBL7839959 0.73 MTNR1A (0.59) MTNR1AMTNR1BHTR2AGPR84LMNA
SCHEMBL9854036 0.73 MTNR1A (0.63) MTNR1AMTNR1BHTR2AGPR84LMNA
SCHEMBL23269820 0.71 GPR84 (0.51) HTR2AGPR84KMT2AHTR1AHTR2C
SCHEMBL17452855 0.70 GPR84 (0.62) MTNR1AMTNR1BHTR2AGPR84SMN1; SMN2
SCHEMBL21754104 0.69 MTNR1A (0.57) MTNR1AMTNR1BHTR2AGPR84LMNA
SCHEMBL21754254 0.69 MTNR1A (0.55) MTNR1AMTNR1BHTR2AGPR84LMNA
SCHEMBL178561 0.68 GPR84 (0.78) MTNR1AMTNR1BHTR2AGPR84MAPT
SCHEMBL9671305 0.68 MTNR1A (0.58) MTNR1AMTNR1BGPR84LMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060235222-A1 Indole-derivative modulators of steroid hormone nuclear receptors ELI LILLY AND COMPANY (US) 2006-10-19 US disclosed
WO-2004067529-A1 INDOLE-DERIVATIVE MODULATORS OF STEROID HORMONE NUCLEAR RECEPTORS ELI LILLY AND COMPANY (US) 2004-08-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060235222-A1 Indole-derivative modulators of steroid hormone nuclear receptors NR3C2, NR5A1, MC2R MTNR1A 32/4885MTNR1B 39/4885HTR2A 164/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.